Scholarly article on 4-bromo-3-oxo-2-o-tolylhydrazono-butyric acid ethyl ester 26502-52-3 from Journal of the Chemical Society C: Organic p. 656

DOI: 10.1039/j39700000656

Source and publish data:

Journal of the Chemical Society C: Organic p. 656 (1970)

Update date:2022-08-03

Topics:

Authors:

Garg Garg

Singh Singh

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/j39700000656

Full text of DOI:10.1039/j39700000656

View Article Online / Journal Homepage / Table of Contents for this issue

View Article Online

Products guided by the article

Product name:4-bromo-3-oxo-2-o-tolylhydrazono-butyric acid ethyl ester

Cas No:26502-52-3

R&D Labs maybe for 26502-52-3

Jiangsu Taihu New Materials Holding Co., Ltd

Contact:+86-519-86160108

Address:Xueyan Town, Changzhou City, Jiangsu Province, 213169, China
Allicon Pharmaceuticals,Inc.

Contact:+86-519-86339586，13584329896

Address:Changzhou Scientific and Education Park
zonk drug r&d limited

Contact:+86-20-32051076

Address:1105,Building A, International Business Incubator,Science City
Tianjin Anda North Industrial & Business Co.Ltd.

Contact:86-22-24999306

Address:No.11 Erwei Road,Dongli Development Area,Tianjin,China
Jiaxing Carry Bio-Chem Technology Co.,Ltd

website:http://www.carrybiotech.com

Contact:0573-82788958

Address:Add.Fl 3th, Pharm Vally,Kaichuang Rd, Xiuzhou District, Jiaxing, Zhejiang,314031,China

Relevant to this article

Reactivity of cyclometallated semicarbazone complexes of Pd(II): Crystal and molecular structures of [Pd{C₆H₄C(Et)=NN(H)C(=O)NH₂}(PPh ₃)][ClO₄] and [Pd{C₆H₄C(Et)=NN(H)C(=O)NH₂}{(Ph ₂PCH₂CH₂)₂PPh-P,P,P}][Cl]

Doi:10.1016/S0022-328X(99)00629-4
(2000)
Doi:10.1080/00268977000100551
(1970)
Synthesis and pharmacological activity of the metabolites of Pratosartan

Doi:10.1248/cpb.54.782
(2006)
Asymmetric mannich synthesis of β-amino acids with two new stereogenic centers at the α and β positions

Doi:10.1002/anie.199703861
(1997)
Pyridyl and furyl epoxides of more than 99% enantiomeric purities: The use of a phosphazene base

Doi:10.1002/(SICI)1099-0690(200003)2000:6<1077::AID-EJOC1077>3.0.CO;2-4
(2000)
14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: Design, synthesis, and biological studies

Doi:10.1016/j.bmcl.2008.12.093
(2009)

Article Doi

DOI: 10.1039/j39700000656